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ANTIBODY CORRELATES OF VACCINE INDUCED PROTECTION AGAINST
EBOLA VIRUS INFECTION IN NONHUMAN PRIMATES

Sudil Mahendra and Nancy J. SuUivan*
Biology Department, Illinois Wesleyan University, and
The National Institutes of Health

The Ebola virus is a single-stranded RNA virus that causes Ebola hemorrhagic fever. A vaccine
candidate for the Ebola virus was developed in the lab of Dr. Nancy J. Sullivan at the National
Institutes of Health using the wild-type Ebola surface glycoprotein (GP). However, due to
concerns with in vitro cytotoxicity, a point mutant (PM) version of the GP vaccine was created.
However, the PM GP vaccine lost a correlate of survival in the process; the IgG concentration in
the blood serum of immunized non-human primates was no longer correlated with survival. We
hypothesized that antibody avidity, a qualitative property, correlates with survival when ELISA
IgG titers do not discern meaningful differences. We tested this hypothesis by measuring the
avidity in sera from vaccinated macaques with a modified ELISA that compares antibody
binding in the presence of urea. The avidity values measured did not provide a significant
correlate of survival.

